Ajman, VAE: The Gulf Medical University (GMU), Ajman, celebrated the outstanding success of the first Thumbay International Research Grant (TIRG) at a Grand Award ceremony on April 15, 2025, which coincided with the annual research day of the GMU. The groundbreaking initiative, supported by the VAE of the Thumbay Group, drew global attention for her mission, to promote effective research in healthcare through international cooperation and innovation.
His sovereignty Sheikh Ammar bin Humaid al Nuaimi, Crown Prince of Ajman, was the main guest And was by He Dr. Sheikh Majeed bin Saeed Al Nauimi, Chairman Herrschricht, reflects, who personally granted the research grants to the winners.
With an initial financing pool of 3 million, the scholarship project in key areas such as precision medicine, recognition of medicinal products and cancer should support the population health in connection with diabetes, healthy aging and regeneration medicine, AI, computer science and digital transformation in healthcare and health economy as well as innovations in health.
Dr. Thumbay Mooiden, founder of the Gulf Medical University and President of the Thumbay Group, repeated the vision behind this initiative: “We launched this grant to transform Gulf Medical University into a stroke for research.” And he also announced that the overall research grant will reach up to 10 million AED after three years, which increases the long -term obligation to present research research.
Prof. Manda Venkatramana, reigning Chancellor at Gulf Medical University, commented: “The grant has made an inspiring start, and the diversity and quality of the submissions reflects the growing global call of GMU. We are proud to support research that have the potential to change and increase healthcare.”
The TIRG initiative continues to underline GMUS engagement for the establishment of international research partnerships and the promotion of an innovation culture. It offers researchers around the world the opportunity to work with the GMU academic community and to consolidate the role of the university as the regional market leader for medical training and research.
Prof. Saleem Chouib, Vice Chancellor – Research, Gulf Medical University, added: “The quality and originality of the selected research projects are really extraordinary and show the innovative spirit of global science. The international research scholarship from Thumbay International is a strong catalyst for groundbreaking research and international cooperation.”
Institutes that were selected for the Thumbay International Research Grant 2025:
domain | Belonging of the Pi | Project title |
Health profession | Harvard Medical School, Boston | Integration of clinical neurology -RX bricks in preclinical neuroscience education: effects on commitment, learning results and neurophobia |
Aritificial Intelligence | University of Arizona | Use of the global flu view for AI-controlled digital transformation in healthcare |
Population health | University of Waterloo, Canada | Promotion of health assessment for older adults with Middle East and North Africa Use of amateur evaluation systems (Menaulas) |
Precision medicine | Regensburg University, Germany | Establishment of new therapeutic strategies to improve the reactivity of cancer cells compared to targeting and immunotherapies |
Precision medicine | Policlinico hospitals gathered Italy, Italy | Hypoxy -gene signature as a promising biomarker to improve patient management of pancreatic cancer |
Health profession | Erasmus University Rotterdam, Netherlands | Improvement of the lessons of clinical thinking with chatgpt |
Precision medicine | Lebanian university, Lebanon | A prospective clinical study on minimally invasive implantology techniques for areas with limited bone height and narrow burrs in healthy and diabetic patients |
Precision medicine | Beirut Arabic University, Lebanon | Comparative study on the effects of water whistle and cigarette smoking: metabolomics and tumorous effects |
Precision medicine | Alexandria University, Egypt | A precision medicine approach to predict the immunotherapy reaction in HCC: integration of molecular PD-L1 profile creation, clinical data and machine learning. |
Drug discovery/precision medicine | RAK Medical and Health Sciences University, VAE | Precision Trojan Horse approach for triple negative breast cancer: doxorubicin and dapagliflozin-pegylated nanoparticles that aim at CD44-positive cancer stem cells and immune background paths |
Precision medicine | Mohammed bin Rashid University of Medicine and Health Sciences, United Arab Emirates | Disorder of the Trim28 complex: a potential combination therapy approach with immune checkpoint inhibitors in TNBC |
Precision medicine | Ajman University, VAE | The role of pre -unit and CID1067700 in skin regeneration and wound healing |
Precision medicine | University of Sharjah, Vae | Relief of hypoxia as a means of improving the reaction of pancreatic cancer to immunotherapy |
Precision medicine | Al Ain University, VAE | Targeting of the metabolism for personalized improvement in chemotherapeutic effectiveness in breast cancer |